Lilly receives UK marketing authorisation for tirzepatide (Mounjaro) in alternative Kwikpen presentation for two indications
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Eli Lilly’s tirzepatide...
